EUVIMEDEUVIMED entdecken
Crossref

Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer

Shan-Shan Jiang, Yi-Le Xie, Xiu-Ying Xiao, Zi-Ran Kang, Xiao-Lin Lin, Lu Zhang, Chu-Shu Li, Yun Qian, Ping-Ping Xu, Xiao-Xu Leng, Li-Wei Wang, Shui-Ping Tu und 9 weitere

Cell Host & Microbe · 2023-05 · 31 (5) · 781-797.e9

DOI: 10.1016/j.chom.2023.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2023-05. Verfasst von Shan-Shan Jiang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fusobacterium Infections. Die Arbeit wurde bisher 441-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade therapy with anti-PD-1 monoclonal antibody (mAb) is a treatment for colorectal cancer (CRC). However, some patients remain unresponsive to PD-1 blockade. The gut microbiota has been linked to immunotherapy resistance through unclear mechanisms. We found that patients with metastatic CRC who fail to respond to immunotherapy had a greater abundance of Fusobacterium nucleatum and increased succinic acid. Fecal microbiota transfer from responders with low F. nucleatum, but not F. nucleatum-high non-responders, conferred sensitivity to anti-PD-1 mAb in mice. Mechanistically, F. nucleatum-derived succinic acid suppressed the cGAS-interferon-β pathway, consequently dampening the antitumor response by limiting CD8+ T cell trafficking to the tumor microenvironment (TME) in vivo. Treatment with the antibiotic metronidazole reduced intestinal F. nucleatum abundance, thereby decreasing serum succinic acid levels and resensitizing tumors to immunotherapy in vivo. These findings indicate that F. nucleatum and succinic acid induce tumor resistance to immunotherapy, offering insights into microbiota-metabolite-immune crosstalk in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsFusobacterium InfectionsAnimalsMiceFusobacterium nucleatumSuccinic AcidImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

Fusobacterium nucleatumcGAS-IFN-β pathwaycolorectal cancerimmunotherapysuccinic acid

Substanzen

Succinic Acid

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, S…
  • Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Förderung

  • National Key Research and Development Program of China
  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Hospital Development Center
  • Shanghai Municipal Health Commission

Zitieren

APA

Jiang, S. S., Xie, Y. L., Xiao, X. Y., Kang, Z. R., Lin, X. L., Zhang, L., Li, C. S., Qian, Y., Xu, P. P., Leng, X. X., Wang, L. W., Tu, S. P., Zhong, M., Zhao, G., Chen, J. X., Wang, Z., Liu, Q., Hong, J., Chen, H. Y., …, & Fang, J. Y. (2023). Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host & Microbe, 31(5), 781-797.e9. https://doi.org/10.1016/j.chom.2023.04.010

Vancouver

Jiang SS, Xie YL, Xiao XY, Kang ZR, Lin XL, Zhang L, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host & Microbe. 2023;31(5):781-797.e9. doi:10.1016/j.chom.2023.04.010

BibTeX
@article{Jiang2023,
  author = {Jiang, Shan-Shan and Xie, Yi-Le and Xiao, Xiu-Ying and Kang, Zi-Ran and Lin, Xiao-Lin and Zhang, Lu and Li, Chu-Shu and Qian, Yun and Xu, Ping-Ping and Leng, Xiao-Xu and Wang, Li-Wei and Tu, Shui-Ping and Zhong, Ming and Zhao, Gang and Chen, Jin-Xian and Wang, Zheng and Liu, Qiang and Hong, Jie and Chen, Hao-Yan and Chen, Ying-Xuan and Fang, Jing-Yuan},
  title = {Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer},
  journal = {Cell Host & Microbe},
  year = {2023},
  volume = {31},
  number = {5},
  pages = {781--797.e9},
  doi = {10.1016/j.chom.2023.04.010}
}
Kostenlos starten →